Newbridge Financial Services Group’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-89
Closed -$10.1K 1057
2024
Q4
$10.1K Sell
89
-10
-10% -$1.14K ﹤0.01% 736
2024
Q3
$11.8K Sell
99
-125
-56% -$11.5K ﹤0.01% 418
2024
Q2
$18K Sell
224
-281
-56% -$25.7K 0.01% 591
2024
Q1
$46.6K Sell
505
-349
-41% -$33.5K 0.02% 406
2023
Q4
$90.1K Sell
854
-266
-24% -$26.8K 0.04% 291
2023
Q3
$122K Hold
1,120
0.06% 257
2023
Q2
$121K Sell
1,120
-57
-5% -$6.41K 0.06% 272
2023
Q1
$147K Sell
1,177
-18
-2% -$2.47K 0.08% 249
2022
Q4
$180K Sell
1,195
-90
-7% -$13.8K 0.1% 194
2022
Q3
$173K Sell
1,285
-192
-13% -$29.4K 0.1% 204
2022
Q2
$220K Sell
1,477
-54
-4% -$8.25K 0.14% 152
2022
Q1
$261K Sell
1,531
-92
-6% -$15.5K 0.13% 154
2021
Q4
$418K Hold
1,623
0.2% 105
2021
Q3
$443K Sell
1,623
-1,448
-47% -$460K 0.28% 84
2021
Q2
$688K Buy
3,071
+334
+12% +$63K 0.42% 45
2021
Q1
$299K Sell
2,737
-128
-4% -$13.6K 0.22% 113
2020
Q4
$234K Buy
+2,865
New +$281K 0.19% 113

Other funds holding BNTX

Newbridge Financial Services Group's BNTX Position: Q1 2025 in Review

Newbridge Financial Services Group sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 89 shares — an estimated $10.1K sold.

Newbridge Financial Services Group first reported a position in BNTX in Q4 2020 and held it in 17 quarters. The position peaked at $688K in Q2 2021. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Newbridge Financial Services Group reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Newbridge Financial Services Group sold 89 BioNTech shares in Q1 2025, an estimated $10.1K.
  • Newbridge Financial Services Group first reported a position in BioNTech in Q4 2020 and held it in 17 quarters.
  • Newbridge Financial Services Group's BioNTech position peaked at $688K in Q2 2021.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Newbridge Financial Services Group's 13F filing for Q1 2025, filed 15 May 2025.